Table 2. PCa specific characteristics of cases selected from PCBaSe 3.0.
| Variable | Cases n (%) |
Controls n (%) |
|---|---|---|
| Gleason Score | ||
| <7 | 3263 (37.24) | - |
| 7 | 3285 (37.49) | - |
| >7 | 1982 (22.62) | - |
| Missing data | 232 (2.65) | - |
| T Stage | ||
| T0 | 31 (0.35) | - |
| T1a | 263 (3.00) | - |
| T1b | 157 (1.79) | - |
| T1c | 4083 (46.60) | - |
| T2 | 2421 (27.63) | - |
| T3 | 1350 (15.41) | - |
| T4 | 280 (3.20) | - |
| TX | 171 (1.95) | - |
| Missing data | 6 (0.07) | - |
| N-Stage | ||
| N0 | 1960 (22.37) | - |
| N1 | 220 (2.51) | - |
| NX | 6567 (74.95) | - |
| Missing data | 15 (0.17) | - |
| M-Stage | ||
| M0 | 7957 (90.81) | - |
| M1 | 788 (8.99) | - |
| MX | 2 (0.02) | - |
| Missing data | 15 (0.17) | - |
| Number of biopsy cores taken | ||
| <10 | 2265 (25.85) | - |
| 10–19 | 5723 (65.32) | - |
| 20–29 | 45 (0.51) | - |
| 30+ | 4 (0.05) | - |
| None | 725 (8.27) | - |
| Number of biopsy cores with cancer | ||
| 0 | 1 (0.01) | - |
| 1–4 | 5012 (57.20) | - |
| 5–9 | 2313 (26.40) | - |
| 10–14 | 605 (6.90) | - |
| 15+ | 1 (0.01) | - |
| None | 830 (9.47) | - |
| PSA at time of diagnosis (μg/ml) | ||
| Median (IQR) | 8.6 (15.7) | - |
PSA = prostate specific antigen.